22. 8. 2024

Research Programme 5: Translational oncology – Verification clinical studies of the proof-of-concept type

Molecular changes associated with malignant transformation (including driver mutations and mechanisms of metastasis), tumour microenvironment, and detailed molecular characterisation of cancer aimed at finding personalised therapeutic plans for precision oncology are the three key areas of research presented by the programme’s main leaders Karel Smetana and Ondřej Slabý.
12. 6. 2024

Research Programme 3: Biomarkers of Cancers and Cancer Diagnostics

Molecular changes associated with malignant transformation (including driver mutations and mechanisms of metastasis), tumour microenvironment, and detailed molecular characterisation of cancer aimed at finding personalised therapeutic plans for precision oncology are the three key areas of research presented by the programme’s main leaders Karel Smetana and Ondřej Slabý.
12. 4. 2024

Research Programme 4: Early Detection and Prevention of Tumours

What are the main goals of this research programme of the NICR? How well are they being met? What successes did your colleagues and groups involved in research in the area of early detection and prevention of tumours already achieve? You will find answers to these questions and more in an article prepared by heads of this programme, Petr Džubák and Marek Svoboda.